Literature DB >> 33498697

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors.

Chad Compagner1, Corey Lester1, Michael Dorsch1.   

Abstract

BACKGROUND: Depression affects millions worldwide, with drug therapy being the mainstay treatment. A variety of factors, including personal reviews, are involved in the success or failure of medication therapy. This study looked to characterize the sentiment of online medication reviews of Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitor (SNRIs) used to treat depression.
METHODS: The publicly available data source used was the Drug Review Dataset from the University of California Irvine Machine Learning Repository. The dataset contained the following variables: ID, drug name, condition, review, rating, date, and usefulness count. This study utilized a sentiment analysis of free-text, online reviews via the sentimentr package. A Mann-Whitney U test was used for comparisons.
RESULTS: The average sentiment was higher in SSRIs compared to SNRIs (0.065 vs. 0.005, p < 0.001). The average sentiment was also found to be higher in high-rated reviews than in low-rated reviews (0.169 vs. -0.367, p < 0.001). Ratings were similar in the high-rated SSRI group and high-rated SNRI group (9.19 vs. 9.19).
CONCLUSIONS: This study supports the use of sentiment analysis using the AFINN lexicon, as the lexicon showed a difference in sentiment between high-rated reviews from low-rated reviews. This study also found that SNRIs have more negative sentiment and lower-rated reviews than SSRIs.

Entities:  

Keywords:  SNRI; SSRI; antidepressant; depression; emotion; sentiment

Year:  2021        PMID: 33498697      PMCID: PMC7924400          DOI: 10.3390/pharmacy9010027

Source DB:  PubMed          Journal:  Pharmacy (Basel)        ISSN: 2226-4787


  7 in total

1.  What do patients learn about psychotropic medications on the web? A natural language processing study.

Authors:  Kamber L Hart; Roy H Perlis; Thomas H McCoy
Journal:  J Affect Disord       Date:  2019-09-10       Impact factor: 4.839

2.  Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.

Authors:  Diana M Sobieraj; Brandon K Martinez; Adrian V Hernandez; Craig I Coleman; Joseph S Ross; Karina M Berg; David C Steffens; William L Baker
Journal:  J Am Geriatr Soc       Date:  2019-05-29       Impact factor: 5.562

3.  Practice guideline for adult mayor depressive disorder.

Authors:  G M Van Kempen
Journal:  Am J Psychiatry       Date:  1994-04       Impact factor: 18.112

4.  Sentiment analysis to determine the impact of online messages on smokers' choices to use varenicline.

Authors:  Nathan K Cobb; Darren Mays; Amanda L Graham
Journal:  J Natl Cancer Inst Monogr       Date:  2013-12

5.  Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study.

Authors:  Roger S McIntyre; Rita Prieto; Patricia Schepman; Yu-Chen Yeh; Matthieu Boucher; Ahmed Shelbaya; Richard Chambers; Xin Gao; Elizabeth Pappadopulos
Journal:  Curr Med Res Opin       Date:  2019-09-16       Impact factor: 2.580

6.  Indian nursing students' attitudes toward mental illness and persons with mental illness.

Authors:  Vanteemar S Sreeraj; Seema Parija; N A Uvais; Sandhyarani Mohanty; Sudhir Kumar
Journal:  Ind Psychiatry J       Date:  2017 Jul-Dec

7.  Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019.

Authors:  David M Kern; M Soledad Cepeda; Frank Defalco; Mila Etropolski
Journal:  BMC Psychiatry       Date:  2020-01-03       Impact factor: 3.630

  7 in total
  1 in total

1.  Discussions of Asperger Syndrome on Social Media: Content and Sentiment Analysis on Twitter.

Authors:  Elia Gabarron; Anders Dechsling; Ingjerd Skafle; Anders Nordahl-Hansen
Journal:  JMIR Form Res       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.